The overexpression of NLRP1 and increased levels of IL-1β in the tumor microenvironment have been emphasized to promote breast cancer malignity, progression, and migration (Elaraj et al. 2006; Wei et al. 2017). The gene discussed is NLRP1; the disease is breast carcinoma.